UnitedHealth Group Incorporated with ticker code (UNH) have now 24 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between $635.51 and $433.08 calculating the mean target price we have $535.34. Given that the stocks previous close was at $478.99 this would imply there is now a potential upside of 11.8%. There is a 50 day moving average of $489.44 while the 200 day moving average is $507.95. The total market capitalization for the company now stands at 454.68B. The current share price for the company is: $493.18 USD
The potential market cap would be $508,169,414,900 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 30.13, revenue per share of $411.26 and a 7.09% return on assets.
UnitedHealth Group Incorporated is a diversified health care company that operates Optum and UnitedHealthcare platforms. Its segments include Optum Health, Optum Insight, Optum Rx and UnitedHealthcare. Optum Health segment is focused on care delivery, care management, wellness and consumer engagement, and health financial services. Optum Insight segment serves the needs of hospital systems, physicians, health plans, governments and life sciences companies. Optum Rx segment offers pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, purchasing and clinical capabilities, and develops programs in areas such as step therapy, formulary management, drug adherence and disease/drug therapy management. UnitedHealthcare includes the combined results of operations of UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State and UnitedHealthcare Global.
